IBDEI1K5 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27992,1,5,0)
 ;;=5^Anxiolytic Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,27992,2)
 ;;=^331936
 ;;^UTILITY(U,$J,358.3,27993,0)
 ;;=305.42^^172^1778^26
 ;;^UTILITY(U,$J,358.3,27993,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27993,1,2,0)
 ;;=2^305.42
 ;;^UTILITY(U,$J,358.3,27993,1,5,0)
 ;;=5^Anxiolytic Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,27993,2)
 ;;=^331937
 ;;^UTILITY(U,$J,358.3,27994,0)
 ;;=305.51^^172^1778^69
 ;;^UTILITY(U,$J,358.3,27994,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27994,1,2,0)
 ;;=2^305.51
 ;;^UTILITY(U,$J,358.3,27994,1,5,0)
 ;;=5^Opioid Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,27994,2)
 ;;=^268244
 ;;^UTILITY(U,$J,358.3,27995,0)
 ;;=305.52^^172^1778^70
 ;;^UTILITY(U,$J,358.3,27995,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27995,1,2,0)
 ;;=2^305.52
 ;;^UTILITY(U,$J,358.3,27995,1,5,0)
 ;;=5^Opioid Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,27995,2)
 ;;=^268245
 ;;^UTILITY(U,$J,358.3,27996,0)
 ;;=305.61^^172^1778^41
 ;;^UTILITY(U,$J,358.3,27996,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27996,1,2,0)
 ;;=2^305.61
 ;;^UTILITY(U,$J,358.3,27996,1,5,0)
 ;;=5^Cocaine Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,27996,2)
 ;;=^268247
 ;;^UTILITY(U,$J,358.3,27997,0)
 ;;=305.62^^172^1778^42
 ;;^UTILITY(U,$J,358.3,27997,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27997,1,2,0)
 ;;=2^305.62
 ;;^UTILITY(U,$J,358.3,27997,1,5,0)
 ;;=5^Cocaine Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,27997,2)
 ;;=^268248
 ;;^UTILITY(U,$J,358.3,27998,0)
 ;;=305.71^^172^1778^17
 ;;^UTILITY(U,$J,358.3,27998,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27998,1,2,0)
 ;;=2^305.71
 ;;^UTILITY(U,$J,358.3,27998,1,5,0)
 ;;=5^Amphetamine Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,27998,2)
 ;;=^268251
 ;;^UTILITY(U,$J,358.3,27999,0)
 ;;=305.72^^172^1778^18
 ;;^UTILITY(U,$J,358.3,27999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27999,1,2,0)
 ;;=2^305.72
 ;;^UTILITY(U,$J,358.3,27999,1,5,0)
 ;;=5^Amphetamine Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,27999,2)
 ;;=^268252
 ;;^UTILITY(U,$J,358.3,28000,0)
 ;;=305.91^^172^1778^77
 ;;^UTILITY(U,$J,358.3,28000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28000,1,2,0)
 ;;=2^305.91
 ;;^UTILITY(U,$J,358.3,28000,1,5,0)
 ;;=5^Other Drug Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,28000,2)
 ;;=^268259
 ;;^UTILITY(U,$J,358.3,28001,0)
 ;;=305.92^^172^1778^78
 ;;^UTILITY(U,$J,358.3,28001,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28001,1,2,0)
 ;;=2^305.92
 ;;^UTILITY(U,$J,358.3,28001,1,5,0)
 ;;=5^Other Drug Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,28001,2)
 ;;=^268260
 ;;^UTILITY(U,$J,358.3,28002,0)
 ;;=V65.2^^172^1779^33
 ;;^UTILITY(U,$J,358.3,28002,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28002,1,2,0)
 ;;=2^V65.2
 ;;^UTILITY(U,$J,358.3,28002,1,5,0)
 ;;=5^Malingering
 ;;^UTILITY(U,$J,358.3,28002,2)
 ;;=^92393
 ;;^UTILITY(U,$J,358.3,28003,0)
 ;;=V65.49^^172^1779^38
 ;;^UTILITY(U,$J,358.3,28003,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28003,1,2,0)
 ;;=2^V65.49
 ;;^UTILITY(U,$J,358.3,28003,1,5,0)
 ;;=5^Other Specified Counseling
 ;;^UTILITY(U,$J,358.3,28003,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,28004,0)
 ;;=V61.10^^172^1779^43
 ;;^UTILITY(U,$J,358.3,28004,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28004,1,2,0)
 ;;=2^V61.10
 ;;^UTILITY(U,$J,358.3,28004,1,5,0)
 ;;=5^Partner Relational Problem
 ;;^UTILITY(U,$J,358.3,28004,2)
 ;;=^74110
 ;;^UTILITY(U,$J,358.3,28005,0)
 ;;=V61.20^^172^1779^41
 ;;^UTILITY(U,$J,358.3,28005,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28005,1,2,0)
 ;;=2^V61.20
 ;;^UTILITY(U,$J,358.3,28005,1,5,0)
 ;;=5^Parent-Child Problem NOS
 ;;^UTILITY(U,$J,358.3,28005,2)
 ;;=^304300
